Cingulate Therapeutics

Pharmaceutical company · Kansas City, Kansas, United States

Cingulate Therapeutics is a pharmaceutical company headquartered in Kansas City, Kansas, United States. Its earliest recorded incorporation is in 2012. It has reported private securities offerings to the US SEC, most recently $26 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Cingulate Therapeutics at a glance

Typepharmaceutical company

HeadquartersKansas City, Kansas, United States

Earliest incorporation on record2012

SEC CIK1593151

What does Cingulate Therapeutics do?

Private fundraising reported to the SEC

7 Form D notices; the most recent reported $26.2 million sold (2020).

Frequently asked questions about Cingulate Therapeutics

Where is Cingulate Therapeutics headquartered?

Cingulate Therapeutics is headquartered in Kansas City, Kansas, United States.

What does Cingulate Therapeutics do?

Cingulate Therapeutics is a pharmaceutical company.

When was Cingulate Therapeutics founded?

The earliest incorporation on record for Cingulate Therapeutics is in 2012, according to public company registers.

Similar companies

Orbis Biosciences, Inc.Kansas City, Missouri, United States
Cingulate Inc.Kansas City, Kansas, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Dare Bioscience, Inc.San Diego, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences